Kazera Global PLC Receipt of second tranche of investment (2933W)

TIDMKZG

RNS Number : 2933W

Kazera Global PLC

17 August 2022

17 August 2022

Kazera Global plc

("Kazera" or the "Company")

Receipt of second tranche of investment

Kazera Global plc, the AIM quoted investment company, is pleased to advise that, further to the 26 July 2022 announcement of the receipt of the first tranche of the investment in the Company's new lithium JV and produced from the Company's wholly owned mine at Tantalite Valley, Namibia, that the Company has now received the second payment of US$ 400,000 in accordance with the terms of the transformational deal on Lithium announced on 20 July 2022.

Dennis Edmonds, Kazera Chief Executive Officer, c ommented:

"We are pleased to confirm the timely receipt of the second instalment of the investment under the lithium deal, highlighting Xinjian's positive outlook for Kazera's JV.

We are now focused on maximising this investment in our Namibia operations with a view to also substantially increasing Tantalum production this year, and to commencing lithium sales in Q1 2023 for which the global energy landscape and the importance of materials linked to the electric revolution continues to grow apace by the day.."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014 ('MAR'). Investor Presentation.

For further information on the Company, visit: www. kazeraglobal .com

 
  Kazera Global plc (c/o Camarco)                  Tel: [phone] 
   Dennis Edmonds (CEO) 
 
    finnCap (Nominated Adviser and Joint             Tel: [phone] 
    Broker) 
    Christopher Raggett / Tim Harper (Corporate      Tel: [phone] 
    Finance) 
 
    Peterhouse Capital Limited (Joint Broker) 
    Duncan Vasey and Lucy Williams (Corporate 
    Broker) 
 
    Camarco (PR)                                   Tel: [phone] 
    Gordon Poole / James Crothers / Hugo 
    Liddy 
 

**ENDS**

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGUGDIIXBDGDR

(END) Dow Jones Newswires

August 17, 2022 02:00 ET (06:00 GMT)